270 related articles for article (PubMed ID: 15710617)
61. Interflavin electron transfer in human cytochrome P450 reductase is enhanced by coenzyme binding. Relaxation kinetic studies with coenzyme analogues.
Gutierrez A; Munro AW; Grunau A; Wolf CR; Scrutton NS; Roberts GC
Eur J Biochem; 2003 Jun; 270(12):2612-21. PubMed ID: 12787027
[TBL] [Abstract][Full Text] [Related]
62. Characterization of recombinant Bacillus megaterium cytochrome P-450 BM-3 and its two functional domains.
Li HY; Darwish K; Poulos TL
J Biol Chem; 1991 Jun; 266(18):11909-14. PubMed ID: 1904873
[TBL] [Abstract][Full Text] [Related]
63. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
[TBL] [Abstract][Full Text] [Related]
64. Mutants of Cytochrome P450 Reductase Lacking Either Gly-141 or Gly-143 Destabilize Its FMN Semiquinone.
Rwere F; Xia C; Im S; Haque MM; Stuehr DJ; Waskell L; Kim JJ
J Biol Chem; 2016 Jul; 291(28):14639-61. PubMed ID: 27189945
[TBL] [Abstract][Full Text] [Related]
65. Novel haem co-ordination variants of flavocytochrome P450BM3.
Girvan HM; Toogood HS; Littleford RE; Seward HE; Smith WE; Ekanem IS; Leys D; Cheesman MR; Munro AW
Biochem J; 2009 Jan; 417(1):65-76. PubMed ID: 18721129
[TBL] [Abstract][Full Text] [Related]
66. Optimisation of Cytochrome P450 BM3 Assisted by Consensus-Guided Evolution.
Vincent T; Gaillet B; Garnier A
Appl Biochem Biotechnol; 2021 Sep; 193(9):2893-2914. PubMed ID: 33860879
[TBL] [Abstract][Full Text] [Related]
67. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
Davis CA; Dhawan IK; Johnson MK; Barber MJ
Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
[TBL] [Abstract][Full Text] [Related]
68. Structural and Kinetic Studies of Asp632 Mutants and Fully Reduced NADPH-Cytochrome P450 Oxidoreductase Define the Role of Asp632 Loop Dynamics in the Control of NADPH Binding and Hydride Transfer.
Xia C; Rwere F; Im S; Shen AL; Waskell L; Kim JP
Biochemistry; 2018 Feb; 57(6):945-962. PubMed ID: 29308883
[TBL] [Abstract][Full Text] [Related]
69. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
70. Flavocytochrome P450 BM3 mutant A264E undergoes substrate-dependent formation of a novel heme iron ligand set.
Girvan HM; Marshall KR; Lawson RJ; Leys D; Joyce MG; Clarkson J; Smith WE; Cheesman MR; Munro AW
J Biol Chem; 2004 May; 279(22):23274-86. PubMed ID: 15020591
[TBL] [Abstract][Full Text] [Related]
71. Analysis of the structural stability of the multidomain enzyme flavocytochrome P-450 BM3.
Munro AW; Lindsay JG; Coggins JR; Kelly SM; Price NC
Biochim Biophys Acta; 1996 Sep; 1296(2):127-37. PubMed ID: 8814218
[TBL] [Abstract][Full Text] [Related]
72. Structural and spectroscopic characterization of P450 BM3 mutants with unprecedented P450 heme iron ligand sets. New heme ligation states influence conformational equilibria in P450 BM3.
Girvan HM; Seward HE; Toogood HS; Cheesman MR; Leys D; Munro AW
J Biol Chem; 2007 Jan; 282(1):564-72. PubMed ID: 17077084
[TBL] [Abstract][Full Text] [Related]
73. P450BM-3; a tale of two domains--or is it three?
Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
[TBL] [Abstract][Full Text] [Related]
74. Expression and characterization of ferredoxin and flavin adenine dinucleotide binding domains of the reductase component of soluble methane monooxygenase from Methylococcus capsulatus (Bath).
Blazyk JL; Lippard SJ
Biochemistry; 2002 Dec; 41(52):15780-94. PubMed ID: 12501207
[TBL] [Abstract][Full Text] [Related]
75. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
Urlacher VB; Schmid RD
Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
[No Abstract] [Full Text] [Related]
76. Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide synthase. Comparisons with NADPH-cytochrome P450 oxidoreductase.
Zhang J; Martàsek P; Paschke R; Shea T; Siler Masters BS; Kim JJ
J Biol Chem; 2001 Oct; 276(40):37506-13. PubMed ID: 11473123
[TBL] [Abstract][Full Text] [Related]
77. Structural and spectroscopic analysis of the F393H mutant of flavocytochrome P450 BM3.
Ost TW; Munro AW; Mowat CG; Taylor PR; Pesseguiero A; Fulco AJ; Cho AK; Cheesman MA; Walkinshaw MD; Chapman SK
Biochemistry; 2001 Nov; 40(45):13430-8. PubMed ID: 11695889
[TBL] [Abstract][Full Text] [Related]
78. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
79. Characterization of the structure and interactions of P450 BM3 using hybrid mass spectrometry approaches.
Jeffreys LN; Pacholarz KJ; Johannissen LO; Girvan HM; Barran PE; Voice MW; Munro AW
J Biol Chem; 2020 May; 295(22):7595-7607. PubMed ID: 32303637
[TBL] [Abstract][Full Text] [Related]
80. Quantitation of FAD-dependent cytochrome P450 reductase activity by photoreduction.
Hodgson AV; Strobel HW
Anal Biochem; 1996 Dec; 243(1):154-7. PubMed ID: 8954538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]